Rigel Pharmaceuticals, Inc. (RIGL) Reports In-Line Q1 Loss

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• L3Harris CEO steps down amid conduct review, shares drop
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'